Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2

Journal of Clinical Investigation

Volumn 116, Issue 5, 2006, Pages 1425-1434

  Selander, Barbro ^a   Mårtensson, Ulla ^a   Weintraub, Andrej ^b   Holmström, Eva ^a   Matsushita, Misao ^c   Thiel, Steffen ^d   Jensenius, Jens C ^d   Truedsson, Lennart ^a   Sjöholm, Anders G ^a,e  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TOKAI UNIVERSITY   (Japan)

^d AARHUS UNIVERSITY   (Denmark)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; FICOLIN; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEASE 2; O ANTIGEN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP TYPING; COMPLEMENT ALTERNATIVE PATHWAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MICROTITER PLATE ASSAY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C3; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; LIPOPOLYSACCHARIDES; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; OLIGOSACCHARIDES; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM;

EID: 33646404373     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25982     Document Type: Article

References (60)

1. Turner, M.W., and Hamvas, R.M. 2000. Mannose-binding lectin: structure, function, genetics and disease associations. Rev. Immunogenet. 39:305-322.
2. Hoffmann, J.A., Kafator, F.C., Janeway, C.A., Jr., and Ezekowitz, R.A.B. 1999. Phylogenetic perspectives in innate immunity. Science. 284:1313-1318.
3. Holmskov, U., Thiel, S., and Jensenius, J.C. 2003. Collectins and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21:547-578.
4. Matsushita, M., and Fujita, T. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1497-1502.
5. Thiel, S., et al. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386:506-510.
6. Dahl, M.R., et al. 2001. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 15:127-135.
7. Stover, C.M., et al. 1999. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 162:3481-3490.
8. Matsushita, M., and Fujita, T. 2002. The role of ficolins in innate immunity. Immunobiology. 205:490-497.
9. Suankratay, C., Zhang, X.-H., Chang, Y., Lint, T.F., and Gewurz, H. 1998. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160:3006-3013.
10. Walport, M.J. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058-1066.
11. Matsushita, M., Thiel, S., Jensenius, J.C., Terai, I., and Fujita, T. 2000. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165:2637-2642.
12. Rossi, V., et al. 2001. Substrate specificieties of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J. Biol. Chem. 276:40880-40887.
13. Ambrus, G., et al. 2003. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J. Immunol. 170:1374-1382.
14. Vorup-Jensen, T., et al. 2000. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J. Immunol. 165:2093-2100.
15. Matsushita, M., and Fujita, T. 1995. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. Immunobiology. 194:443-448.
16. Yu, C.Y. 1998. Molecular genetics of the human MHC complement gene cluster. Exp. Clin. Immunogenet. 15:213-230.
17. Figueroa, J.E., and Densen, P. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359-395.
18. Pickering, M.C., Botto, M., Taylor, P.R., Lachmann, P.J., and Walport, M.J. 2001. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76:227-324.
19. Steffensen, R., Thiel, S., Varming, K., Jersild, C., and Jensenius, J.C. 2000. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods. 241:33-42.
20. Madsen, H.O., et al. 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155:3013-3020.
21. Chernyak, A., Weintraub, A., Norberg, T., and Kallin, E. 1990. Preparation of oligosaccharide-polyacrylamide conjugates and their use as antigens in enzyme immunoassay (EIA). Glycoconj. J. 7:111-120.
22. Grossman, N., Svensson, S.B., Leive, L., and Lindberg, A.A. 1990. Salmonella O-antigen-specific oligosaccharide-octyl conjugates activate complement via the alternative pathway at different rates depending on the structure of the O-antigen. Mol. Immunol. 27:859-865.
23. Schweinle, J.E., Ezekowitz, R.A.B., Tenner, A.J., Kuhlman, M., and Joiner, K.J. 1989. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J. Clin. Invest. 84:1821-1829.
24. Jönsson, G., et al. 2005. Hereditary C2 deficiency in Sweden. Frequent occurrence of invasive infection, atherosclerosis and rheumatic disease. Medicine (Baltimore). 84:23-34.
25. Selander, B., et al. 1999. Low concentrations of immunoglobulin G antibodies to Salmonella serogroup C in C2 deficiency: suggestion of a mannan-binding lectin pathway-dependent mechanism. Scand. J. Immunol. 50:555-561.
26. Nordin Fredriksson, G., et al. 1998. Characterization of non-expressed C4 genes in a case of complete C4 deficiency: identification of a novel point mutation leading to a premature stop codon. Hum. Immunol. 59:713-719.
27. Sjöholm, A.G., Selander, B., Östenson, S., Holmstöm, E., and Söderström, C. 1991. Normal human serum depleted of C1q, factor D and properdin: its use in studies of complement activation. APMIS. 99:1120-1128.
28. Roos, A., et al. 2004. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur. J. Immunol. 34:2589-2598.
29. Knutzen Steuer, K.L., et al. 1989. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement. J. Immunol. 143:2256-2261.
30. Roos, A., et al. 2001. Human IgA activates the complement system via the mannan-binding lectin pathway.J. Immunol. 167:2861-2868.
31. Seelen, M.A., et al. 2005. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods. 296:187-198.
32. Fries, L.F., Gaither T.A., Hammer, C.H., and Frank, M.M. 1984. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J. Exp. Med. 160:1640-1655.
33. Meri, S., and Pangburn, M.K. 1990. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b. Eur. J. Immunol. 20:2555-2561.
34. Petersen, S.V., et al. 2000. Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 37:803-811.
35. Cooper, N.R. 1985. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37:151-207.
36. Laurell, A.-B., Mårtensson, U., and Sjöholm, A.G. 1987. C1 dissociation. Spontaneous generation in human serum of a trimer containing C1 inactivator, activated C1r, and zymogen C1s. J. Immunol. 139:4145-4151.
37. Wouters, D., et al. 2005. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation. J. Immunol. Methods. 298:35-45.
38. Junker, A., et al. 1998. Binding of properdin to solid-phase antigen-antibody complexes: critical role of the classical activation pathway of complement. Scand. J. Immunol. 47:481-486.
39. Krarup, A., Thiel, S., Hansen, A., Fujita, T., and Jensenius, J.C. 2004. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279:47513-47519.
40. Wiese, A., Brandenburg, K., Ulmer, A.J., Seydel, U., and Müller-Loennies, S. 1999. The dual role of lipopolysaccharide as effector and target molecule. Biol. Chem. 380:767-784.
41. Pillemer, L., Schoenberg, M.D., Blum, L., and Wurz, L. 1955. Interaction of the properdin system with polysaccharides. Science. 122:545-549.
42. Vukajlovich, S.W., Hoffman, J., and Morrison, D.C. 1987. Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathway. Mol. Immunol. 24:319-331.
43. Kuhlman, M., Joiner, K., and Ezekowitz, A.B. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1733-1745.
44. Sturfelt, G., and Sjöholm, A.G. 1984. Complement components, complement activation and the acute phase response in systemic lupus erythematosus. Int. Archs. Allergy Appl. Immunol. 75:75-83.
45. Garred, P., et al. 1999. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 42:2145-2152.
46. Stengaard-Pedersen, K., et al. 2003. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med. 349:554-560.
47. Jansson, P.E., et al. 1985. Structural studies of the O-antigen polysaccharides of Klebsiella O5 and Escherichia coli O8. Carbohydr. Res. 45:59-66.
48. Staaf, M., Widmalm, G., Weintraub, A., and Nataro, J.P. 1995. Structural studies of the O-antigenic polysaccharide from Escherichia coli O44:H18. Eur. J. Biochem. 233:473-477.
49. Yildirim, H., Weintraub, A., and Widmalm, G. 2001. Structural studies of the O-polysaccharide from the Escherichia coli O77 lipopolysaccharide. Carbohydr. Res. 333:179-183.
50. Tack, B.J., and Prahl, J.W. 1976. Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 15:4513-4521.
51. Vorup-Jensen, T., et al. 2001. Recombinant expression of human mannan-binding lectin. Int. Immunopharmacol. 1:677-687.
52. Johnson, U., Truedsson, L., and Gustavii, B. 1983. Complement components in 100 newborns and their mothers determined by electroimmunoassay. Acta Pathol. Microbiol. Immunol. Scand. (C). 91:147-150.
53. Ngan, B-Y., Gelfand, E.W., and Minta, J.O. 1977. A simple one-step hemolytic assay for C2 with C2-deficient human serum. J. Immunol. 118:736-741.
54. Cooper, N.R. 1988. Laboratory investigation of complement proteins and complement receptors. Baillieres Clin. Immunol. Allergy. 2:263-293.
55. Terai, I., Kobayashi, K., and Fujita, T. 1997. Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum. Clin. Exp. Immunol. 110:317-323.
56. Møller-Kristensen, M., et al. 2003. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J. Immunol. Methods. 282:159-167.
57. Sjöholm, A.G., Truedsson, L., and Jensenius, J.C. 2001. Complement pathways and meningococcal disease. Diagnostic aspects. In Meningococcal disease. Methods and protocols. A.J. Pollard and M.C.J. Maiden, editors. Humana Press. Totowa, New Jersey, USA. 529-547.
58. Kihlberg, B.-M., Sjöholm, A.G., Björck, L., and Sjöbring, U. 1996. Protein LG - a powerful immunoglobulin-binding hybrid protein. Eur. J. Biochem. 240:556-563.
59. Voller, A., Bidwell, D.E., and Bartlett, A. 1976. Enzyme immuno-assays in diagnostic medicine. Bull. World Health Organ. 53:55-65.
60. Lund, E.D., Sørensen, L.S., and Brandslund, I. 1990. Specificities of monoclonal antibodies against the C3d split product. Complement Inflamm. 7:18-29.